AstraZeneca (AZN.L) and Daiichi Sankyo (4568.T) on Friday secured U.S. approval that broadens the use of their therapy Enhertu, for patients with breast cancer,...
Read moreAdenine base editors were successfully created by GenKOre, a biotech startup in South Korea, using its unique hypercompact gene-editing method....
Read moreFollowing NICE's recommendation of a novel therapy alternative for diabetic macular oedema (DMO), thousands of patients could receive transformative care....
Read moreCould the Senate adopt a "watershed" bill allowing drug price discussions after years of government inaction regarding medication prices in the...
Read moreAccording to the US Department of Health and Human Services, booster shots from Moderna and Pfizer that have been upgraded...
Read moreIn a phase 1/2 clinical trial for patients with locally advanced or metastatic solid tumours, Tallac Therapeutics has reported that...
Read morePfizer previously held out hope that Eucrisa would become the trendiest topical treatment for inflammatory skin conditions. However, the ointment...
Read moreThe use of excessively fragile efficacy data and delays in sponsors' presenting living proof from post-approval trials, as well as...
Read moreAccording to research, the ratio of nicotinic acid (NA) to nicotinamide (NAM) considerably rises when living microorganisms are present inside...
Read morePfizer is prepared and equipped to continue its pandemic sales supremacy, the company's chief executive said on a July 28Â investor...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.